Non-Biological Complex Drugs : The Science and the Regulatory Landscape /
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
| Edition: | 1st ed. 2015. |
| Series: | AAPS Advances in the Pharmaceutical Sciences Series,
20 |
| Subjects: |
Table of Contents:
- Introduction: Defining the position of Non-Biological Complex Drugs
- Polymeric micelles
- Liposomes: the science and the regulatory landscape
- Glatiramoids
- Iron carbohydrate complexes: characteristics and regulatory challenges
- Drug Nanocrystals
- Analytical methods for determining the size (distribution) in parenternal dispersions
- NBCD Pharmacokinetics and Bioanalytical Methods to Measure Drug Release
- Low Molecular Weight Heparins, Biological Drugs close to Non-Biological Complex Drugs
- Nanoparticle Albumin-Bound Anticancer Agents
- The EU regulatory landscape of Non-Biological Complex Drugs
- What did we learn? What can we expect in the future? Concluding remarks and outstanding issues.